Posted: 14 September
In June 2022, the Department of Jobs, Precincts and Regions (the department) invited BioMelbourne Network to join an Industry Reference Group (IRG) to help contribute to discussions to support potential options for the GSK Boronia site redevelopment, in which we enthusiastically accepted.
As some of our members will know, GSK will cease production at the end of 2022 with decommissioning activities planned in the 2nd quarter 2023. The department in partnership with Charter Hall has engaged EY to develop an options opportunity piece to support the continuance of a Life Sciences Precinct at the Boronia site.
The IRG consists of participants from DJPR, GSK, Monash University, MTP Connect, Knox City Council, AMMC along with other key industry leaders.
The group has been formed to:
Act as a governance mechanism and provide inputs into the development of the business case and options for consideration by Charter Hall and the Victorian Government.
Provide input into options that develops the site as a Life Sciences Precinct which is consistent with the Victorian Government’s Medtech and Pharmaceutical Sector Strategy in seeking to capture high-value manufacturing and supports the State’s intention to build capabilities in areas like medicine manufacture, rapid diagnostics testing, cell therapies, clinical trials infrastructure and vaccines.
Provide insight and advice on the recommendations and options being developed by EY for consideration by Charter Hall and the Victorian Government.
Provide insights on strategy to increase the competitive success of Victorian medtech manufacturers by retaining and expanding the key equipment and assets on the site.
The first IRG meeting was held at the GSK Boronia site in June, then another in July in Melbourne to formally workshop a Vision Statement and hear the views of other industry participants including case study examples of Life Sciences Precincts around the world.
The IRG will actively pursue development of opportunities from industry who may wish to utilise the location for manufacturing of pharmaceuticals or medical devices, for research and development, education or for other purposes. If you have interest in learning more about the site or have an opportunity you’d like to discuss, feel free to reach out to me at jmalone@biomelbourne.org for an initial discussion or directly to Nick Lidonnici, Regional Portfolio Manager- Industrial and logistics for Charter Hall.
Mobile +61 447 546 659
email: Nick.Lidonnici@charterhall.com.au
Look forward to hearing from you!
